Literature DB >> 3440798

Extracellular matrix-cytoskeletal connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren disease.

J J Tomasek1, R J Schultz, C J Haaksma.   

Abstract

The cellular basis of contracture of the palmar fascia in patients who have Dupuytren disease involves the generation of intracellular force and the transmission of this force to the surrounding tissue. A specialized cell, the myofibroblast, supposedly generates this intracellular force. Recently published studies from our laboratory demonstrated that the cytoskeleton of the myofibroblast contains non-muscle myosin and not smooth-muscle myosin, suggesting that it utilizes a non-muscle contractile system. In addition, these studies identified the extracellular glycoprotein fibronectin, not the basal-lamina-specific glycoprotein laminin, at the surface of myofibroblasts, suggesting that the transmission of the intracellular force to the surrounding tissue also occurs by a non-muscle mechanism. Because of the lack of proteins that are specific to smooth muscle in the specialized cell in Dupuytren disease, we prefer the term specialized contractile fibroblast to describe this type of cell. To determine the mechanism by which the intracellular force may be transmitted to the surrounding tissue, we examined the ultrastructure of the connection of the cytoskeleton of the specialized contractile fibroblast to the surrounding extracellular matrix. By electron microscopy, extracellular filamentous material was identified at the surface of the specialized contractile fibroblast. These extracellular fibrils were found to be in close association with intracellular bundles of actin microfilaments, resulting in specialized transmembranous associations at the surface of the specialized contractile fibroblast. Bundles of filamentous extracellular material were found to extend from the surface of the specialized contractile fibroblast, connecting it with the surrounding matrix and also with adjacent specialized contractile fibroblasts.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440798

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  11 in total

1.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

2.  WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues.

Authors:  Justin Crawford; Christina Raykha; Daevina Charles; Bing Siang Gan; David B O'Gorman
Journal:  J Cell Commun Signal       Date:  2015-06-30       Impact factor: 5.782

3.  [Radiotherapy in the early stage of Dupuytren's disease. The indications, technic and long-term results].

Authors:  L Keilholz; M H Seegenschmiedt; A D Born; R Sauer
Journal:  Strahlenther Onkol       Date:  1997-01       Impact factor: 3.621

Review 4.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

5.  Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGFβ Type 1 Receptor Modulation by Antisense Oligonucleotides.

Authors:  Sofia Karkampouna; Boudewijn Pt Kruithof; Peter Kloen; Miryam C Obdeijn; Annelies Ma van der Laan; Hans J Tanke; Dwi U Kemaladewi; Willem Mh Hoogaars; Peter Ac 't Hoen; Annemieke Aartsma-Rus; Ian M Clark; Peter Ten Dijke; Marie-José Goumans; Marianna Kruithof-de Julio
Journal:  Mol Ther Nucleic Acids       Date:  2014-01-21       Impact factor: 10.183

Review 6.  Collagenase Clostridium histolyticum: emerging practice patterns and treatment advances.

Authors:  David Warwick; José M Arandes-Renú; Giorgio Pajardi; Jörg Witthaut; Lawrence C Hurst
Journal:  J Plast Surg Hand Surg       Date:  2016-04-06

7.  Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro.

Authors:  Jeffrey C Howard; Vincenzo M Varallo; Douglas C Ross; James H Roth; Kenneth J Faber; Benjamin Alman; Bing Siang Gan
Journal:  BMC Musculoskelet Disord       Date:  2003-07-16       Impact factor: 2.362

8.  Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.

Authors:  Raymond Tse; Jeffrey Howard; Yan Wu; Bing Siang Gan
Journal:  BMC Musculoskelet Disord       Date:  2004-11-12       Impact factor: 2.362

9.  Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.

Authors:  Evert-Jan P M Ten Dam; Marike M van Beuge; Ruud A Bank; Paul M N Werker
Journal:  J Cell Commun Signal       Date:  2015-12-03       Impact factor: 5.782

10.  Inhibition of Contractile Function in Human Joint Capsule Myofibroblasts by Targeting the TGF-β1 and PDGF Pathways.

Authors:  Stefan G Mattyasovszky; Jochen Wollstädter; Anne Martin; Ulrike Ritz; Andreas Baranowski; Christian Ossendorf; Pol M Rommens; Alexander Hofmann
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.